跳至主要内容
临床试验/NCT06400082
NCT06400082进行中(未招募)不适用

Investigating the Impact of Topical Insulin on Postoperative Wound Healing in Diabetic and Non-Diabetic Patients: A Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2023年4月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
74
试验地点
1
主要终点
Calculation of Unit Healing Time index

研究概览

简要总结

This study aimed to investigate the potential effect of applying topical insulin therapy on the management and healing of postoperative wounds in patients known with type 2 diabetes mellitus (T2DM) and in a parallel group without diabetes. Investigators also studied the effect of topical insulin therapy on the expression of e-cadherin and Ki67, as markers for cellular proliferation and wound repair. The levels of IL-6 and the H2O2-induced DNA damage product, 8-hydroxy-2'-deoxyguanosine (8-OHdG), were assessed as markers for inflammation and oxidative stress. Finally, histomorphological assessment of skin biopsies was also carried out.

详细描述

The study participants will be recruited from general surgery department ,all patients with elective surgical procedure who will be admitted at the department for at least one week as it is the minimal duration of postoperative wound healing and the study will be conducted according to the regulations of ethical committee of clinical studies in the Faculty of Medicine, Cairo University

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Both males and females
  • 40-60 years old
  • diagnosed with type 2 DM (for the diabetic trial)
  • For the diabetic trial: glycosylated hemoglobin (HBA1c) ≤7.5 %
  • haemoglobin (Hb) ≥ 12 g/dl
  • Patients who had a full thickness post-operative wound of ≥10 cm

排除标准

  • Those with known history of immunodeficiency, keloid formation, or hyperkeratotic skin lesion.
  • Patients who had hypersensitivity to insulin,
  • Patients with severe infection,
  • Patients with any severe organ dysfunction
  • Patients who were admitted to ICU

研究组 & 干预措施

Povidone iodine 10%

Active Comparator

干预措施: Povidone-Iodine (Drug)

Topical insulin

Experimental

干预措施: Insulin (Drug)

结局指标

主要结局

Calculation of Unit Healing Time index

时间窗: Before and after 7 days of therapy

The total healing days and the surface area of the wound will be combined to report unit healing time in units

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omnia Azmy Nabeh

Principal investigator

Cairo University

研究点 (1)

Loading locations...

相似试验